Gastroenterological Endoscopy. Группа авторов

Ther. 2015; 13(1):95–103

      [13] Cuker A, Siegal DM, Crowther MA, Garcia DA. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. J Am Coll Cardiol. 2014; 64(11):1128–1139

      [14] Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016; 48(4):385–402

      [15] Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006; 27(22):2667–2674

      [16] Siegal D, Yudin J, Kaatz S. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 2012; 126(13):1630–1639

      [17] Hui AJ, Wong RM, Ching JY. et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc. 2004; 59(1):44–48

      [18] Kim HG, Friedland S. Safe and effective colon polypectomy in patients receiving uninterrupted anticoagulation: can we do it? Gastrointest Endosc. 2014; 79(3):424–426

      [19] Nishimura RA, Otto CM, Bonow RO, et al; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(23):e521–e643

      [20] Weitz JI, Quinlan DJ, Eikelboom JW. Periprocedural management and approach to bleeding in patients taking dabigatran. Circulation. 2012; 126(20):2428–2432

      [21] Dzik WS. Reversal of drug-induced anticoagulation: old solutions and new problems. Transfusion. 2012; 52(Suppl 1):45S–55S

      [22] Baron TH, Kamath PS, McBane RD. New anticoagulant and antiplatelet agents: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2014; 12(2):187–195

      [23] Holbrook A, Schulman S, Witt DM, et al; American College of Chest Physicians. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2, Suppl):e152S–e184S

      [24] Tripodi A. The laboratory and the new oral anticoagulants. Clin Chem. 2013; 59(2):353–362

      [25] Kaatz S, Kouides PA, Garcia DA, et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol. 2012; 87(Suppl 1):S141–S145

      [26] Siegal DM, Cuker A. Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis. 2013; 35(3):391–398

      Section III

      General Diagnostic and Therapeutic Procedures and Techniques

       12 Upper Gastrointestinal Endoscopy

       13 Enteroscopy Techniques

       14 Wireless Video Capsule Endoscopy

       15 Colonoscopy: Preparation, Instrumentation and Technique

       16 Endoscopic Retrograde Cholangiopancreatography

       17 Cholangioscopy

       18 Advanced Imaging Methods

       19 The Contribution of Histopathology to Endoscopy

       20 Endoscopic Ultrasonography

       21 Hybrid, Natural Orifice, and Laparoscopy-Assisted Endoscopy: New Paradigms in Minimally Invasive Therapy